Profile

Emirhan Harbi

Bahcesehir University
Bahcesehir University

Contact Details

Bio

My interests:
Adrenal Medulla Tumors; Pheochromocytoma and Paraganglioma; Nuclear Medicine/Molecular Imaging; CNS Malignancies; PCNA Mechanism; DNA Repair and DNA Damage Response (DDR); Cancer Signaling Pathways; Molecular Oncology; Diagnostic Adrenal and Neuroradiology; Neuroendocrine Tumors; PRRT.

My Publications:
 1-) Harbi, E., Yildiz, O., & Aschner, M. (2025). Potential Risks of Minoxidil in Pheochromocytoma and Paraganglioma: A Commentary on Safety Concerns and Mechanisms. Molecular neurobiology, https://doi.org/10.1007/s12035-025-04842-4 
2-) Harbi, E., & Aschner, M. (2025). Von Hippel-Lindau syndrome: clinical features, genetic foundations, and management strategies. Molecular biology reports, 52(1), 281. https://doi.org/10.1007/s11033-025-10403-8 
3-) Harbi, E., & Aschner, M. (2025). Nuclear medicine and perspective thoughts in the diagnosis and treatment of pheochromocytoma and paraganglioma. Journal of neuroendocrinology, e70017. https://doi.org/10.1111/jne.70017 
4-) Harbi, E., & Aschner, M. (2024). Role of BRCA1 in glioblastoma etiology. Cellular oncology, 47(6), 2091-2098. https://doi.org/10.1007/s13402-024-01024-7
5-) Harbi, E., & Aschner, M. (2024). Nuclear Medicine Imaging Techniques in Glioblastomas. Neurochemical research, 49(11), 3006–3013. https://doi.org/10.1007/s11064-024-04233-6